Cited by 334Hepatitis C virus researchHepatitis Viruses Studies and EpidemiologyHelicobacter pylori-related gastroenterology studies

Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa

Madhava, Valsa, Burgess, Christine, Drucker, Ernest·2002·The Lancet Infectious Diseases

Abstract

Hepatitis C virus (HCV) is a major cause of chronic liver disease in the world. The WHO estimates that 3% (170 million) of the world's population are chronically infected with HCV. Sub-Saharan Africa is of great interest because it is reported to have the highest HCV prevalence rate (5.3%), and a concurrent HIV epidemic. In our review of the published literature we found consistent evidence of high HCV prevalence in many countries of Africa. We estimate the overall prevalence of HCV in Sub-Saharan Africa is 3.0%. The central African region has the highest estimated prevalence of 6%, west Africa has an estimated prevalence of 2.4%, and southern and east Africa with the lowest estimated prevalence of 1.6%. Given low sexual transmission of HCV and infrequency of intravenous drug use in Sub-Saharan Africa, iatrogenic causes of HCV transmission need to be further evaluated.

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(02)00264-5

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Madhava, V., Burgess, C., & Drucker, E.
Affiliations
  • Albert Einstein College of Medicine (US)
  • World Health Organization (CH)
Corresponding author
Madhava, Valsa
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2002-05
Volume
2
Issue
5
Pages
293-302
ISSN
1473-3099 (ISSN-L)
OpenAlex
W2145708303
Cited by
334
References
33
Citations by year
2026: 3 · 2025: 7 · 2024: 3 · 2023: 7 · 2022: 8 · 2021: 16 · 2020: 8 · 2019: 12 · 2018: 22 · 2017: 15 · 2016: 23 · 2015: 20 · 2014: 29 · 2013: 23 · 2012: 13
FWCI
1.51
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatitis C virus research
  • Health Sciences › Medicine › Hepatology › Hepatitis Viruses Studies and Epidemiology
  • Health Sciences › Medicine › Surgery › Helicobacter pylori-related gastroenterology studies
Keywords
hepatitis C virus, chronic hepatitis C, HCV prevalence, sub-Saharan Africa, HIV coinfection, HCV transmission, iatrogenic transmission, sexual transmission, intravenous drug use, chronic liver disease
MeSH terms
Adult, Epidemiologic Methods, Humans, Middle Aged, Prevalence, Africa South of the Sahara, Hepatitis C, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review